Feature Channels: Autoimmune Diseases

Filters close
Released: 8-Jan-2024 4:05 PM EST
UTHealth Houston study: EBV-specific T-cells play key role in development of multiple sclerosis
University of Texas Health Science Center at Houston

The body’s immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       
Newswise: NUS researchers develop an innovative and flexible method to study immune cell capabilities
Released: 17-Dec-2023 9:05 PM EST
NUS researchers develop an innovative and flexible method to study immune cell capabilities
National University of Singapore (NUS)

Researchers from the National University of Singapore (NUS) devise a simple and innovative way to directly identify and sort the immune cells involved in cell-mediated cytotoxicity.

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 16-Nov-2023 3:05 AM EST
Fourth dose of COVID vaccine boosts protection in patients with rheumatic disease
Mass General Brigham

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.

Newswise: Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Released: 14-Nov-2023 10:00 AM EST
Researchers Explore Origins of Lupus, Find Reason for Condition’s Prevalence Among Women
Johns Hopkins Medicine

For years, researchers and clinicians have known that lupus, an autoimmune condition, occurs in women at a rate nine times higher than in men.

Released: 7-Nov-2023 10:05 AM EST
Mayo Clinic Laboratories and Progentec® collaborate to bring advanced biomarker testing services to patients with autoimmune diseases
Mayo Clinic

Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, today announced a strategic collaboration to bring Progentec’s suite of proprietary biomarker blood tests for the proactive management of autoimmune diseases to market.

Released: 1-Nov-2023 7:05 PM EDT
Study provides preliminary evidence in favor of a new type 1 diabetes treatment
University of Chicago Medical Center

A new study led by researchers at UChicago Medicine and Indiana University suggests that an existing drug could be repurposed to treat type 1 diabetes, potentially reducing dependence on insulin.

Newswise: Repurposed drug offers new potential for managing type 1 diabetes
Released: 1-Nov-2023 4:05 PM EDT
Repurposed drug offers new potential for managing type 1 diabetes
Indiana University

A new study published in Cell Reports Medicine presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The study's findings' suggest repurposing of the drug α-difluoromethylornithine (DFMO) may open doors to innovative therapies.

Released: 24-Oct-2023 1:35 PM EDT
From nanoplastics to airborne toxins: Pollution stories for media.
Newswise

Read the latest research news on air pollution, nanoplastics, waterborne illnesses and more in the Pollution channel on Newswise.

       
Released: 12-Oct-2023 9:05 AM EDT
Association for Molecular Pathology Publishes Best Practice Recommendations for Liquid Biopsy Assay Validations
Association for Molecular Pathology

The Association for Molecular Pathology has published best practice recommendations for validating and reporting clinical circulating tumor DNA (ctDNA) or liquid biopsy assays and their related scientific publications.

Newswise: Could Ginger Help Treat Autoimmune Disease Symptoms?
Released: 11-Oct-2023 2:25 PM EDT
Could Ginger Help Treat Autoimmune Disease Symptoms?
Michigan Medicine - University of Michigan

After ginger root was proven to halt autoimmune disease progression in mice, researchers are now trialing the same concept in humans

Newswise: THE AUTOIMMUNE ASSOCIATION NAMES NEW CHAIR OF MEDICAL AND SCIENTIFIC ADVISORY COUNCIL
Released: 2-Oct-2023 8:00 AM EDT
THE AUTOIMMUNE ASSOCIATION NAMES NEW CHAIR OF MEDICAL AND SCIENTIFIC ADVISORY COUNCIL
Autoimmune Association

The Autoimmune Association announces the appointment of Eline (Nina) T. Luning Prak, MD, PhD, as chair of the organization’s Medical and Scientific Advisory Council.

Newswise: Study identifies new pathway to suppressing autoimmunity
25-Sep-2023 2:05 PM EDT
Study identifies new pathway to suppressing autoimmunity
The Rockefeller University Press

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body’s own, healthy tissues. The study, to be published September 29 in the Journal of Experimental Medicine (JEM), also reveals how this process is impaired in autoimmune disorders such as systemic sclerosis and systemic lupus erythematosus and suggests potential new strategies to treat these diseases.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 23-Aug-2023 1:25 PM EDT
Toppling siloes to link electronic dental and health records
Regenstrief Institute

A new study reports on linking electronic health records and electronic dental records to provide better care and outcomes for individuals with Sjögren's disease.

Released: 23-Aug-2023 12:45 PM EDT
Research identifies immunosuppressed people are least likely to have COVID-19 antibodies
University of Nottingham

New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.

Newswise: Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Released: 18-Aug-2023 12:05 PM EDT
Long-Term Study Reaffirms Benefits of Covid-19 Vaccination for Organ Transplant Recipients
Johns Hopkins Medicine

A two-year study found that spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus’ omicron subvariant.

Newswise: UTSW finds potential key to predict immunotherapy toxicity
Released: 14-Aug-2023 11:50 AM EDT
UTSW finds potential key to predict immunotherapy toxicity
UT Southwestern Medical Center

Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity. The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to improved treatments for a variety of cancers.



close
2.12059